ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C09DA03 | G | Valsartan - 160mg, Hydrochlorothiazide - 25mg | 6854 | 168105/10 | ARBITEN PLUS | 30 | Tablet | Oral | Eva Pharm Plus | Joswe Medical (Jordan Sweden Medical and Sterilization Co) | Jordan | 492,837 L.L | 23.08 | A1 | Joswe Medical (Jordan Sweden Medical and Sterilization Co) | Jordan | 2/1/2023 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C09DA03 | G | Valsartan - 160mg, Hydrochlorothiazide - 25mg | 6573 | 218775/09 | CO-ANGINET | 30 | Tablet, film coated | Oral | Premium Serve Drugstore Co. P.S.D. SAL | The United Pharmaceutical Manufacturing Co Ltd | Jordan | 492,837 L.L | 23.08 | A1 | The United Pharmaceutical Manufacturing Co Ltd | Jordan | 2/1/2023 | 0 | |
C09DA03 | B | Valsartan - 160mg, Hydrochlorothiazide - 25mg | 8819 | 133316/1 | CO-DIOVAN | 28 | Tablet, film coated | Oral | Khalil Fattal & Fils S.A.L. | Pharmaline Licensed by Novartis Pharma AG, Basle, Switzerland | Lebanon | 802,665 L.L | 23.08 | A2 | 2/1/2023 | 0 | |||
C09DA03 | G | Valsartan - 160mg, Hydrochlorothiazide - 25mg | 7936 | 101914/1 | VALUSTAR PLUS | 28 | Tablet, film coated | Oral | Qualipharm | Atlantic Pharma Producoes Farmaceuticas SA | Portugal | 558,108 L.L | 23.08 | A2 | Tecnimede Espana Industria Farmaceutica SA | Spain | 2/1/2023 | 0 | |
C09DA03 | G | Valsartan - 160mg, Hydrochlorothiazide - 25mg | 7894 | 186257/13 | VIOSTAN PLUS 160/25 | 30 | Tablet, film coated | Oral | Benta Trading Co s.a.l. | Benta SAL | Lebanon | 472,973 L.L | 23.08 | A2 | 2/1/2023 | 0 |